iBio IBIO
NASDAQ IBIO
$1.17 +0.00 (+0.00%)
As of: Sep 30, 2026 · 3:59 PM EDT

iBio (IBIO) EV to CFO (2012)

Updated

iBio's (IBIO) EV to CFO came in at 341.09 for fiscal Q3 2012 (quarter ended Mar 31, 2012).

Analysis

iBio (IBIO) EV to CFO (2012) Analysis & Trends

For the trailing twelve months through Mar 31, 2012, EV to CFO at iBio was 339.81.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 iBio 121.75 Mn 121.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 341.09
API Access

iBio EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=IBIO&period=max&api_key=YOUR_API_KEY